NEW YORK (TheStreet) -- In early April, I made the case for prolonged weakness for assets denominated in Japanese yen. This forecast proved largely accurate, as the CurrencyShares Japanese Yen Trust ETF (FXY) is 14% lower on the year; and the yen itself is the second-worst performing developed-market currency relative to the U.S. dollar.
To some, these declines might suggest renewed opportunities to buy. But when we consider the policy outlook at the Bank of Japan, and potential cutbacks in monetary stimulus from the Federal Reserve, there is little reason to believe this downtrend has reached a true bottom.
To the contrary, the yen remains a sell, even at these weaker levels. Major divergences in central bank policy favor the U.S. dollar over its Japanese counterpart, and these are trends that should continue well into 2014. In Japan, the intention has been to ramp up bond-purchasing programs as a means to normalize consumer inflation levels.
Hot Paper Stocks To Invest In 2015: Oncothyreon Inc .(ONTY)
Oncothyreon Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutic products for the treatment of cancer. Its primary product candidate, Stimuvax is in two phase III clinical trials for the treatment of non-small cell lung cancer. The company is also developing PX-866, a small molecule that is in phase II trials for various cancer indications. In addition, it engages in the preclinical development of ONT-10, a cancer vaccine; and ONT-701, a pan-inhibitor of the B-cell lymphoma-2 family of anti-apoptotic proteins. The company operates primarily in the United States and Canada. Oncothyreon Inc. was founded in 1985 and is headquartered in Seattle, Washington.
Advisors' Opinion:- [By Roberto Pedone]
One under-$10 biopharmaceutical player that's starting to move within range of triggering a big breakout trade is Oncothyreon (ONTY), which develops and markets synthetic vaccines and small molecules that treat cancer patients. This stock hasn't done much so far in 2013, with shares down modestly by 3.9%.
If you take a look at the chart for Oncothyreon, you'll notice that this stock has been trending sideways inside of a consolidation chart pattern for the last month and change, with shares moving between $1.63 on the downside and $1.95 on the upside. Shares of ONTY have been finding some buying interest of late right above its 50-day moving average of $1.73 a share. This stock is now starting to push within range of triggering a big breakout trade above the upper-end of its recent sideways trading chart pattern.
Traders should now look for long-biased trades in ONTY if it manages to break out above some near-term overhead resistance levels at $1.93 to $1.95 a share and then once it takes out more resistance at $1.98 a share with high volume. Look for a sustained move or close above those levels with volume that hits near or above its three-month average action of 689,364 shares. If that breakout triggers soon, then ONTY will set up to re-test or possibly take out its next major overhead resistance levels at its 200-day moving average of $2.12 a share to $2.70 a share.
Traders can look to buy ONTY off any weakness to anticipate that breakout and simply use a stop that sits right below its 50-day at $1.73 a share or around more support at $1.63 a share. One can also buy ONTY off strength once it takes out those breakout levels with volume and then simply use a stop that sits a comfortable percentage from your entry point.
- [By Ant贸nio Costa]
Oncothyreon Inc (NASDAQ: ONTY) is firming just above key support at $1.78 and a triangle has taken shape over the last few weeks. The stock is starting to show signs of accumulation with high upside days and low downside days. This stock is poised for a move and I suspect that it will explode to the upside. In addition, Inside trading has been very active over the last month. They are buying now after pausing years.
- [By EP Vantage]
Although the subgroup on which this decision is based was large, many will still consider this a risky basis for further study. Some investors thought it was a risk worth taking: shares in Oncothyreon (ONTY), which licensed the drug to Merck and saw its valuation more than halve on news of the Start failure, were trading 22% higher this morning at $2.19; Merck KGaA stock was little changed. But, in the meantime, tecemotide will struggle to shake off the stain of past failure.
- [By WWW.DAILYFINANCE.COM]
D Dipasupil/FilmMagicJustin Bieber's Someday perfume. Plenty of stocks go up and down in any given week. The gainers inspire us to keep investing. The decliners keep greed in check while reminding us about the risks of the equity markets. Let's go over some of last week's best and worst performers. China Finance Online (JRJC) -- Up 131 percent last week The market's biggest winner last week was China Finance Online, more than doubling after introducing a new trading platform. The Beijing-based financial website operator announced that the new offering was the country's first integrated, Web-based securities trading service platform. At least one noted worrywart disputed the claim. Citron Research -- a popular publisher of bearish reports on stocks -- tweeted that sloppy reporting and a misleading headline were making it seem as if no other online trading platform existed in the world's most populous nation. The bulls won out. Shares of China Finance Online closed sharply higher in each of last week's five trading days. TrueCar (TRUE) -- Up 33 percent last week Closer to home, another online platform moved nicely higher after striking a deal with Chrysler and auto insurer GEICO (BRK-A). TrueCar operates a negotiation-free car buying and selling platform. It launched a platform that could shake up the insurance industry, where roughly 3 million cars are totaled each year. Insurers have typically just written a settlement check and provided a rental car voucher to cover the incident, but TrueCar's new plan would work with launch partners GEICO and Chrysler -- and other members of its insurance affinity partners in the future -- to work with the insured to directly replace the vehicle. TrueCar went public at $9 just three months ago. The stock has been revving higher, going on to more than double in its brief time on the market. American Eagle Outfitters (AEO) -- Up 26 percent last week Shares of American Eagle Outfitters moved higher after it posted b
Best Japanese Companies To Own In Right Now: Core Laboratories N.V. (CLB)
Core Laboratories N.V. engages in the provision of reservoir description, production enhancement, and reservoir management services to the oil and gas industry worldwide. The company�s reservoir description services comprise the characterization of petroleum reservoir rock, fluid, and gas samples; and provision of analytical and field services to characterize properties of crude oil and petroleum products. Its production enhancement products and services relate to reservoir well completions, perforations, stimulations, and production, as well as include integrated services to evaluate the effectiveness of well completions and to develop solutions to increase the effectiveness of enhanced oil recovery projects. The company�s reservoir management services consist of the combination and integration of information from reservoir description and production enhancement services to increase production and enhance recovery of oil and gas from clients' reservoirs. Core Laboratori es N.V. markets and sells its services and products through sales representatives, technical seminars, trade shows, and print advertising, as well as through direct sales force, technical experts, operating managers, sales representatives, and distributors in various markets. The company was founded in 1936 and is based in Amsterdam, the Netherlands.
Advisors' Opinion:- [By Jake L'Ecuyer]
Equities Trading DOWN
Shares of Core Laboratories NV (NYSE: CLB) were 16.38 percent to $158.05 after the company lowered its forecast for the second quarter and FY14.
Best Japanese Companies To Own In Right Now: King George Financial Corp (KGF)
King George Financial Corporation is a Canada-based company. The Company operates in the area of commercial and residential real estate investment holding and development, as well as medium to long term investment in real estate and hotel related marketable securities. The Company has four segments: rental operation, real estate development, management and finance services, and others. Its principle assets include an office building in downtown Vancouver, British Columbia, held through its 100% subsidiary 905 W. Pender Investments Ltd; real estate located in the City of Surrey, British Columbia, held through its subsidiary 0819277 BC Ltd, 0788607 BC Ltd, and 50% ownership interest in Surrey Campus Residences Joint Venture. The real estate assets consist of residential building lots, and investment in common shares of Allied Hotel Properties Inc., a hotel ownership and management company, and United Malayan Land BHD (UML), a Malaysian real estate development company. Advisors' Opinion:- [By Sofia Horta e Costa]
Kingfisher Plc (KGF) declined 5.7 percent to 373.6 pence, its biggest loss in more than two years, after Chief Executive Officer Ian Cheshire said consumer confidence in France ��s still weak with no obvious signs of an imminent improvement.�� Europe�� largest home-improvement retailer also reported same-store sales growth of 0.4 percent for its B&Q chain in the U.K. and Ireland, missing analysts��estimates. France accounted for about 40 percent of its sales and the U.K. for 41 percent, data compiled by Bloomberg showed.
Best Japanese Companies To Own In Right Now: Navios Maritime Partners LP (NMM)
Navios Maritime Partners L.P. (Navios Partners) is an international owner and operator of dry cargo vessels formed by Navios Holdings. Navios GP L.L.C. (the General Partner), a wholly owned subsidiary of Navios Maritime Holdings Inc. (Navios Holdings) acts as the general partner of Navios Partners and received a 2% general partner interest in Navios Partners. Navios Partners is engaged in the seaborne transportation services of a range of drybulk commodities, including iron ore, coal, grain and fertilizer, chartering its vessels under medium to long-term charters. On May 19, 2011, Navios Partners acquired from Navios Holdings the Navios Orbiter, a 76,602 deadweight Panamax vessel. On May 19, 2011, Navios Partners acquired from Navios Holdings the Navios Luz. In June 2012, the Company purchased the Navios Buena Ventura, a 2010 South-Korean-built Capesize vessel of 179,259 dwt from Navios Maritime Holdings Inc.
The Company is an international owner and operator of drybulk carriers formed by Navios Maritime Holdings Inc., a vertically integrated seaborne shipping company. Its vessels are chartered-out under medium to long-term time charters with an average remaining term of approximately four years to a group of counterparties, consisting of Cosco Bulk Carrier Co. Ltd., Mitsui O.S.K. Lines Ltd., Samsun Logix, STX Panocean, Sanko Steamship Co. Ltd., Daiichi Chuo Kisen Kaisha, Augustea Imprese Maritime, Rio Tinto, Constellation Energy Group and Mansel.
As of December 31, 2011, the Company�� fleet consisted of 11 Panamax vessels, six Capesize vessels and one Ultra-Handymax vessel. Its fleet of dry cargo vessels has an average age of approximately 5.6 years. Panamax vessels are flexible vessels capable of carrying a range of drybulk commodities, including iron ore, coal, grain and fertilizer. All of its vessels operate under medium to long-term time charters of three or more years at inception with counterparties. It also operates vessels in the spot market until the vessels have! been fixed under appropriate medium to long-term charters.
The Company competes with China Ocean Shipping, China Shipping Group, Mitsui O.S.K. Lines, Kawasaki Kisen, Nippon Yusen Kaisha, Cargill, Pacific Basin Shipping, Bocimar, Zodiac Maritime, Louis Dreyfus/Cetragpa, Cobelfret and Torvald Klaveness.
Advisors' Opinion:- [By Eric Volkman]
As far as unitholder payouts are concerned, the seas for Navios Maritime Partners (NYSE: NMM ) are calm and smooth. The company has declared its latest quarterly distribution, which is to be $0.4425 per unit paid on Aug. 13 to holders of record as of Aug. 8. That amount matches each of Navios' previous four disbursements, the most recent of which was paid in mid-May. Previous to that, the company handed out a quarter-cent less, at $0.44 per share.
- [By Bryan Murphy]
If you're reading this, then odds are you already know shipping stocks like Diana Shipping Inc. (NYSE:DSX), Safe Bulkers, Inc. (NYSE:SB), and Navios Maritime Partners L.P. (NYSE:NMM) are all up big-time today, and up nicely for the week, for that matter. SB is up 11% for the day, NMM is up 6% for the week, while DSX is higher by 8% for the session, snapping a surprisingly-long weak streak.
- [By Nickey Friedman]
It seems like everybody these days universally agrees that the dry bulk shipping market will get better at least in the short term. Executives from DryShips (NASDAQ: DRYS ) , Navios Maritime Partners (NYSE: NMM ) , Diana Shipping (NYSE: DSX ) , and other carriers have voiced optimism about increased demand for 2014. Even if that optimism is realized, there is another very important factor to watch that could ruin the whole thing.
No comments:
Post a Comment